Jan‐Jong Hung

3.5k total citations
71 papers, 2.8k citations indexed

About

Jan‐Jong Hung is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jan‐Jong Hung has authored 71 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 18 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Jan‐Jong Hung's work include Ubiquitin and proteasome pathways (19 papers), RNA modifications and cancer (10 papers) and RNA Research and Splicing (10 papers). Jan‐Jong Hung is often cited by papers focused on Ubiquitin and proteasome pathways (19 papers), RNA modifications and cancer (10 papers) and RNA Research and Splicing (10 papers). Jan‐Jong Hung collaborates with scholars based in Taiwan, United States and India. Jan‐Jong Hung's co-authors include Wen‐Chang Chang, Jian‐Ying Chuang, Tsung‐I Hsu, Yi-Ting Wang, Ming-Jer Young, Wen Chang, Wu‐Chou Su, Wen‐Bin Yang, Shao‐An Wang and Chuan‐Liang Kao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jan‐Jong Hung

70 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan‐Jong Hung Taiwan 30 1.9k 590 587 340 253 71 2.8k
Etienne P.A. Neve Sweden 22 1.6k 0.9× 449 0.8× 714 1.2× 141 0.4× 265 1.0× 32 2.7k
Abul Bashar Mir Md. Khademul Islam Bangladesh 30 1.7k 0.9× 485 0.8× 517 0.9× 138 0.4× 441 1.7× 87 2.6k
Ke Jiang China 30 1.5k 0.8× 527 0.9× 787 1.3× 285 0.8× 354 1.4× 81 2.6k
Jorge Andrade United States 30 1.7k 0.9× 707 1.2× 633 1.1× 429 1.3× 753 3.0× 73 3.4k
Víctor Segura Spain 33 2.2k 1.2× 463 0.8× 967 1.6× 200 0.6× 425 1.7× 95 3.3k
Min-Jung Lee United States 28 1.8k 1.0× 663 1.1× 234 0.4× 374 1.1× 392 1.5× 96 2.8k
James W. Jacobberger United States 35 2.0k 1.1× 769 1.3× 353 0.6× 461 1.4× 563 2.2× 103 3.4k
Joon‐Yong Chung United States 36 2.4k 1.3× 1.1k 1.9× 835 1.4× 479 1.4× 629 2.5× 175 4.4k
Gangqiao Zhou China 26 1.2k 0.6× 602 1.0× 576 1.0× 205 0.6× 441 1.7× 82 2.4k
Shinichiro Takahashi Japan 26 1.5k 0.8× 403 0.7× 290 0.5× 147 0.4× 427 1.7× 112 2.6k

Countries citing papers authored by Jan‐Jong Hung

Since Specialization
Citations

This map shows the geographic impact of Jan‐Jong Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Jong Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Jong Hung more than expected).

Fields of papers citing papers by Jan‐Jong Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Jong Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Jong Hung. The network helps show where Jan‐Jong Hung may publish in the future.

Co-authorship network of co-authors of Jan‐Jong Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Jong Hung. A scholar is included among the top collaborators of Jan‐Jong Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Jong Hung. Jan‐Jong Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, Ming-Jer, Shao‐An Wang, Chia-Yu Liu, et al.. (2024). USP24-i-101 targeting of USP24 activates autophagy to inhibit drug resistance acquired during cancer therapy. Cell Death and Differentiation. 31(5). 574–591. 14 indexed citations
2.
Hung, Jan‐Jong, et al.. (2024). PTEN decreases NR2F1 expression to inhibit ciliogenesis during EGFRL858R-induced lung cancer progression. Cell Death and Disease. 15(3). 225–225. 1 indexed citations
3.
Young, Ming-Jer, Chia-Yu Liu, Chia-Chi Lee, et al.. (2022). Estradiol-mediated inhibition of DNMT1 decreases p53 expression to induce M2-macrophage polarization in lung cancer progression. Oncogenesis. 11(1). 25–25. 25 indexed citations
4.
Wang, Shao‐An, Ming-Jer Young, Yi-Chang Wang, et al.. (2021). USP24 promotes drug resistance during cancer therapy. Cell Death and Differentiation. 28(9). 2690–2707. 22 indexed citations
5.
Young, Ming-Jer, Kai‐Cheng Hsu, Tony Eight Lin, Wen‐Chang Chang, & Jan‐Jong Hung. (2019). The role of ubiquitin-specific peptidases in cancer progression. Journal of Biomedical Science. 26(1). 42–42. 118 indexed citations
6.
Su, Wen‐Pin, Song‐Bin Chang, Wen‐Tai Chiu, et al.. (2017). Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways. Scientific Reports. 7(1). 3879–3879. 13 indexed citations
7.
Hung, Chia-Yang, Yi-Chang Wang, Jian‐Ying Chuang, et al.. (2017). Nm23-H1-stabilized hnRNPA2/B1 promotes internal ribosomal entry site (IRES)-mediated translation of Sp1 in the lung cancer progression. Scientific Reports. 7(1). 9166–9166. 12 indexed citations
8.
Chang, Kwang‐Yu, Tsung‐I Hsu, Cheng‐Keng Chuang, et al.. (2017). Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma. Biochemical and Biophysical Research Communications. 493(1). 14–19. 25 indexed citations
9.
Hung, Chia-Yang, Wen‐Bin Yang, Shao‐An Wang, et al.. (2014). Nucleolin enhances internal ribosomal entry site (IRES)-mediated translation of Sp1 in tumorigenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(12). 2843–2854. 23 indexed citations
10.
Hsu, Tsung‐I, et al.. (2014). MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy. Oncogene. 34(7). 826–837. 36 indexed citations
11.
12.
Hsu, Tsung‐I, et al.. (2011). Sp1 expression regulates lung tumor progression. Oncogene. 31(35). 3973–3988. 121 indexed citations
13.
Chuang, Jian‐Ying & Jan‐Jong Hung. (2011). Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway. Biochemical and Biophysical Research Communications. 407(3). 587–592. 23 indexed citations
14.
Liu, Yi‐Wen, et al.. (2010). Inhibition of LPS‐induced C/EBPδ by trichostatin a has a positive effect on LPS‐induced cyclooxygenase 2 expression in RAW264.7 cells. Journal of Cellular Biochemistry. 110(6). 1430–1438. 11 indexed citations
15.
Hung, Jan‐Jong, Wen‐Juei Jeng, W. H. Hsu, et al.. (2010). Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax. 65(3). 241–245. 61 indexed citations
16.
Hung, Jan‐Jong, et al.. (2009). Prognostic significance of hypoxia-inducible factor-1 , TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax. 64(12). 1082–1089. 182 indexed citations
17.
Hung, Jan‐Jong, et al.. (2009). Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax. 64(3). 192–196. 115 indexed citations
18.
Yeh, Shiu‐Hwa, Jan‐Jong Hung, Po‐Wu Gean, & Wen‐Chang Chang. (2008). Hypoxia-Inducible Factor-1α Protects Cultured Cortical Neurons from Lipopolysaccharide-Induced Cell Death via Regulation of NR1 Expression. Journal of Neuroscience. 28(52). 14259–14270. 28 indexed citations
19.
Chuang, Jian‐Ying, Yi-Ting Wang, Shiu-Hwa Yeh, et al.. (2008). Phosphorylation by c-Jun NH2-terminal Kinase 1 Regulates the Stability of Transcription Factor Sp1 during Mitosis. Molecular Biology of the Cell. 19(3). 1139–1151. 102 indexed citations
20.
Chang, Wen-Chang, et al.. (2007). Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein δ gene in mouse macrophages. Journal of Biomedical Science. 14(3). 407–418. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Etienne P.A. Neve Breakdown of academic impact, for papers by Abul Bashar Mir Md. Khademul Islam Breakdown of academic impact, for papers by Ke Jiang Breakdown of academic impact, for papers by Jorge Andrade Breakdown of academic impact, for papers by Víctor Segura Breakdown of academic impact, for papers by Min-Jung Lee Breakdown of academic impact, for papers by James W. Jacobberger Breakdown of academic impact, for papers by Joon‐Yong Chung Breakdown of academic impact, for papers by Gangqiao Zhou Breakdown of academic impact, for papers by Shinichiro Takahashi
Rankless by CCL
2026